INTRODUCTION
We are living in a rapidly changing environment marked by economic and social instability. Highly regarded positions such as those of teachers, police and doctors have in recent years been downgraded in many societies with resulting psychologically mediated problems. 1 The emergence of new values has led to the disablement of whole societies, as seen in Eastern Europe during the 90s, where uncertainty, anxiety, job losses, disrespect and, finally, lower life expectancy, have resulted in the excess mortality of over 4 million people. 2, 3 The changes in society are thus likely to influence the working life, quality of life and disease pattern among groups in society over time.
patient is treated, but also correlated morbidity and other aspects of treatment; such as side-effects that make one treatment preferable over another.
Questions such as: What is quality of life, how is it measured, and how can the information be used, are highly relevant in our society where patients have become informed health consumers demanding effective treatment of their symptoms. Today, patients can download information from the Internet, request a particular therapy, disagreeing with the clinician's suggestions. In that situation it is important to have a wider perspective when managing the patient. This article aims to discuss HRQL assessments and how they can be gainfully used in gastroenterology.
DEFINITION AND MEASUREMENT OF HEALTH-RELATED QUALITY OF LIFE
Health-related quality of life is by definition subjective and multidimensional. The purpose of focusing on HRQL is to go beyond the presence and severity of symptoms of disease or side-effects of treatment, examining how patients perceive and experience these manifestations in their daily lives. Key and core domains reflecting HRQL are represented by physical, mental and social functioning. [5] [6] [7] [8] [9] [10] An individual's quality of life is influenced by socioeconomic factors (i.e. a person's financial status affects his/her housing and physical environment, and educational, recreational and cultural opportunities). If a person's income allows him/her to achieve a good nutritional status, enjoy living in the community, and win the respect of his/her neighbors, job satisfaction is likely and physical and emotional well-being are promoted. Other factors are age, gender, disease and treatments, which will be discussed below.
Quality of life instruments
The best and most relevant way of assessing HRQL is to ask the patient. This is usually done by using standardized and scientifically well-documented questionnaires. The questionnaires can be roughly divided into two kinds: generic and condition or disease specific. To this one can also add preference-based and, possibly, a newly developed measure, the (World Health Organization Quality of Life (WHOQOL), which measures general quality of life across different cultures. [11] [12] [13] Advantages and shortcomings associated with generic and disease-specific instruments are shown in Table 1. 14 Hundreds of instruments have been developed. In 1995, it was estimated that over 70 generic and over 300 disease-specific instruments have been used in different studies. 13 The instruments can be interviewbased or self-administered questionnaires. Questionnaires are usually preferred as the interviewer may influence interview-based evaluations. The questionnaires also have the advantage of being possible to use in different cultures and languages and in clinical trials in a more standardized way.
Generic instruments
Generic questionnaires enable clinicians and investigators to comprehensively evaluate the impact of different diseases and symptoms on the patients' HRQL. They can be used to compare scores with those of other groups in a population with or without diseases. They are also particularly useful in patients with multiple problems, severe disease, in the elderly, disabled, handicapped, and those with functional disorders where objective end-points may be lacking. A number of generic instruments have been developed in several languages and can thus be used for comparisons in differ- 17 There are also abbreviated versions of SF-36 in SF-20 and SF-12, which take less time to apply but are less reliable. The SF-36 is widely used in gastroenterology and enables general comparisons between different patient groups. 15, 16, 18 The generic instruments include a broad range of aspects such as physical, emotional and social functioning, role performance and perceived health. They are therefore less sensitive to changes in specific symptoms but more reliable in addressing their general impact on a wide range of daily activities, mental health and functioning.
Preference-based measures, previously used for economic evaluations, are represented by the Quality of Well-Being Scale (QWB), the Health Utilities Indexes (HUI) and the EuroQol Instrument (EQ-5D) and are intended to be used for economic evaluation. 12, [19] [20] [21] [22] The QWB is preference based, which means that the patients value different situations. It has fewer domains than the other generic instruments and does not assess psychological distress. It is useful for longitudinal assessment of patients and in clinical trials and has been shown to be responsive to clinical improvement in multiple conditions.
19,22-25

Disease-specific instruments
The specific nature of a disease is best followed with a specific instrument. Disease-specific instruments are by definition disease oriented and do not allow comparisons with other illnesses and, in particular, specialists often regard them as more useful clinically. As they address specific diseases they are considerably more sensitive to the effects of interventions and time trends in a specific disease condition. Therefore, they are often seen as less burdensome to patients, office staff and physicians. However, due to their narrow focus, they may fail to detect important unexpected changes. Many disease-specific instruments have recently been developed in the field of gastroenterology, hepatology and cancer care. 13, 26, 27 Generally, disease-specific measures have been more systematically developed and evaluated. The specific instruments differ considerably. The Gastrointestinal Quality of Life Index 28 covers symptoms such as pain, bloating, strength endurance, sadness, nervousness, dysphagia and diarrhea, which enables it to be used fairly widely in GI disorders. The Gastrointestinal Symptom Rating Scale [29] [30] [31] is more closely connected with symptoms from the gastrointestinal (GI) tract, specifically reflux, dyspepsia and symptoms from the lower bowel. For inflammatory bowel disease (IBD), there are several well-documented questionnaires that have been used in randomized clinical trials. One is the IBDQ, developed by Irvine et al. 32 This instrument closely follows Crohn´s Disease Activity Index (CDAI) development, while Rating Form of IBD Patient Concerns (RFIPC), developed by Drossman et al. 33 is better at detecting worries and concern, and the Ulcerative Colitis and Crohn's Disease Health Status Scales (UCCDHSS) 34 focuses on measuring severity of symptoms.
The growing clinical interest in the area of dyspepsia and reflux has led to the development of several questionnaires. Quality of Life in Reflux and Dyspepsia (QOLRAD) was developed fairly recently, 35 specifically for evaluations of dyspepsia and gastroesophageal reflux disease (GERD) by targeting the particular areas of distress and dysfunction described by patients with these conditions.
Instruments have also been developed for dyspepsia and irritable bowel syndrome (IBS). The DHSI developed by Shaw and coworkers takes into account the difficulty caused by the overlapping symptomatology of IBS and dyspepsia. The DHSI incorporates both Rome criteria and the Manning criteria. 36 Several new measures have recently been developed for use in patients with dyspepsia and IBS. [37] [38] [39] [40] [41] [42] [43] In liver disease, the quality of life aspects may be of primary importance, and many instruments have been developed. Generic and disease-specific instruments have also been combined, as in the case of Hepatitis Quality of Life Questionnaire (HQLQ).
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How reliable and valid are the healthrelated quality of life results and how can we interpret them?
Patient reported outcome measures used to describe the burden of illness or used as end-points in clinical trials need to satisfy certain sets of psychometric criteria. 46 The evaluations of the instruments are based on reliability and validity, and of particular pertinence for use in clinical trials, responsiveness to change. Reliability refers to the precision or the reproducibility of a measure (i.e. if it is free from random error). This is usually expressed by a coefficient ranging from 0 to 1, with 1 indicating maximum reliability. A common estimate used is internal consistency, which should usually range from 0.5 to 0.7 for group comparisons and 0.85-0.95 for individual comparisons. [47] [48] [49] [50] It has been argued that internal consistency should be higher, but this would counteract the discrimination needed between different questionnaires. 11 The test/re-test reliability, the correlation between two assessments made, for instance, 7 days apart should be over 0.70. 46 The second variable is validity, which expresses to what degree an instrument measures what it is supposed to. This can be divided into several subsections. 11, 51, 52 Responsiveness to change refers to the ability of a questionnaire to capture small treatment-induced changes over time in conjunction with clinical trials. 46, [53] [54] [55] In Table 2 , the most important factors are listed in more detail.
What is an important difference in scores?
Recently, several attempts have been made to address the important issue of clarifying what is a minimal important change in HRQL scores. Several routes have been suggested, such as an estimation of the effect size, the standardized response mean or by calculating the correlation between change in a clinical parameter with the change in a relevant HRQL domain. [56] [57] [58] [59] Comparison with reference values also represents a viable way of facilitating interpretation of HRQL scores For the SF-36 a change of or a difference in five score units seems to be clinically relevant. 60 Improvement in HRQL was assessed with QOLRAD and a difference of 0.5 scores units between unimportant changes and very important changes was found to be clinically relevant.
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FACTORS INFLUENCING HRQL MEASUREMENTS
The outcomes of quality of life measurements depend on several factors indicated in the Introduction. Some of these are gender, age, expectations, concerns about disease, severity, and also the bias induced by failure to capture the HRQL values in patients leaving trials.
Gender
Several indexes have shown to yield different results in men and women and across different age groups, in the general population as well as in different patient populations. Female individuals were found to have an overall lower score of well-being than males in a normal population 31 and in GERD populations ( Fig. 1) . 35, 63 In a recent publication, female gender, medical conditions and presence of GI symptoms were associated with significantly impaired well-being in daily life. Well-being scores and life scores of an index of daily life were lower among respondents with relevant upper GI symptoms than in those who had no upper GI symptoms. Among upper GI symptom groups, subjects with ulcer-like symptoms had lower scores than patients with GERDlike or dysmotility-like symptoms. The well-being and daily life scores were found to discriminate between respondents reporting different symptom frequencies and severity and the results of the Domestic/ International Gastroenterology Surveillance Study (DIGEST) demonstrate on a large scale the importance of GI symptoms in daily life and their influence on HRQL. 64 
Age
Age is an important factor reflected in quality of life measurements in different age groups. Health-related quality of life appears to be affected by the phase in life an individual has reached. Evaluations have shown that middle-aged individuals have lower values than optimistic young and older patients. If this is related to concerns of daily living, job or other aspects on different stages of life may be discussed. 31, 35 Expectations A patient's emotional status regarding his/her expectations or hope of improvement has a profound effect on HRQL. Patients with severe obesity have low quality of life values before their first visit to the doctor, while these values increase to super-normal levels after they have been informed that they will undergo surgery (H. Glise & B. Hallerbäck, pers. comm., 1997). A similar phenomenon has been seen in patients operated on for reflux disease or medically treated for peptic ulcer, where values are super-normal after surgery or medical treatment but then return to normal after a few months.
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Health concerns
Worries and concerns induced by symptoms often prompt patients to consult. 67 Concern may be gender and anxiety related as suggested by the Patient Unmet Needs Survey (PUNS)-study results. 68 In this study, females had more concerns about various symptoms causing them to consult physicians for heartburn. Male patients with GERD reported more often that their partner encouraged them to see a physician (Fig. 2) .
The influence of concerns also reflects the apparent flaws in HRQL results where low back pain, heartburn or dyspepsia patients are worse than patients with myocardial infarction or angina pectoris. In clinical practice this is generally judged the reverse.
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Severity of symptoms
Overall symptom severity is well reflected in the HRQL evaluations. This may be a result of multiple aspects of anxiety concerns, social situation etc. In studies where HRQL scores have been compared with symptoms obtained by asking questions, there has been good correlation between symptoms and scores (Fig. 3) . 9, 35, 64, 66 Additionally, the occurrence of nocturnal symptoms is associated with an impaired HRQL, particularly if the symptoms are frequent.
69
Disease and disabilities
Disease and disabilities may dramatically influence several of the variables. In some cases, they result in socioeconomic deterioration and emotional crises, with loss of one's job, friends and sexual partners. In others, the support from friends, neighbors and colleagues may actually increase the positive effects of several of these aspects. This may partly explain why evaluations of some clinically serious conditions have shown that quality of life is sometimes less affected than other nonserious or trivial clinical conditions.
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Effect of treatment
Treatment is yet another factor of importance, not only the effect on the specific disease treated but also the side-effects seen with treatments. Good examples of this are side-effects of oncology drugs, where survival, toxicity and the impact of functional status may vary according to the individual's phase of life. 70 This highlights that quality of life measures, per definition, represent the patient's view. It is and always will be subjective and should be so. If we ask for the views of the patient's doctor or relatives, completely different aspects of the situation are incorporated and other results are obtained even when evaluating treatment effect. When evaluating the effect of treatment in clinical trials it is important to control the effect of patients leaving the trial ahead of schedule, see Discussion.
HEALTH-RELATED QUALITY OF LIFE IN GASTROINTESTINAL DISEASE
Health-related quality of life has been evaluated in a number of gastrointestinal conditions, including cancer. 
Inflammatory bowel disease
Inflammatory bowel disease is one of the areas where HRQL instruments were developed early. These conditions may vary considerably due to the degree of inflammation, fistulae, diarrhea with or without bleeding, and inflammation in involved organs such as the liver, joints etc. It is well established that HRQL is low in both ulcerative colitis (UC) and Crohn's disease, and the scores worsen in more severe disease, especially in patients that have required surgery for Crohn's disease. Crohn's disease patients usually have lower scores than UC. 71, 72 The specific areas affected most in IBD have been mental health and social functioning. 73, 74 Compared with patients with arthritis, multiple sclerosis and amyotropic lateral sclerosis (ALS), those with IBD have scored better.
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Gastroesophageal reflux disease
Gastroesophageal reflux is mainly symptomatic in most patients and affects a large proportion of the population. Reflux may affect patients in all phases of their daily living such as work, bending forward, eating, and sleeping. 77 Numerous studies of reflux patients show an impaired HRQL compared with a healthy reference population. 31, 78, 79 Similarly, in a rural primary care population with GERD symptoms, with or without comorbidity, significant deviations were found compared with healthy reference values in terms of impairment in emotional and physical role functioning, pain, health perceptions vitality and mental health. 80 Patients with gastrointestinal conditions have generally been shown to be significantly more impaired than those with other conditions such as arthritis, hypertension and myocardial infarction. 81 This can partly be ascribed to the fact that gastrointestinal conditions affect several of the domains measured. Lack of vitality, emotional distress, pain, limitations in physical and social activities have been found in reflux patients. 82 Sleep disturbance has also been found in patients with heartburn and regurgitation. 69, 83 The difference between symptomatic GERD and reflux esophagitis is seen on endoscopy. In symptomatic terms no differences can generally be found. Nor have the effects on quality of life been correlated to esophagitis. 84, 85 The level of anxiety and pain in heartburn patients has been found to be a factor in predicting effect of treatment (Wiklund et al., unpubl. data, 2001 ). 86 The results of measures before and after surgery and comparisons of medical therapy and surgery are discussed under that heading.
Dyspepsia
Dyspepsia or pain refers to discomfort in the upper abdomen and can include ulcer and reflux disease, while functional dyspepsia involves similar symptoms but without any organic findings on examination with, for example, an endoscopy. The HRQL in these groups has been defined as low and at the same level with or without investigational findings of reflux disease or duodenal ulcer, and the values reflected the intensity of symptoms well. 87, 88 Another factor of importance was the increased pain and anxiety level found in patients with negative endoscopy. 89 
Irritable bowel syndrome
Irritable bowel syndrome has many similarities to dyspepsia, which explains why some questionnaires have been developed for both areas. The SF-36 has shown that HRQL is low in patients with IBS.Values have been found lower than other groups such as diabetes and GERD. Irritable bowel syndrome patients disclose a diversity of HRQL impacts such as pain, poor health, sleep disturbances and a pronounced impact on social functioning and mental health. Dimensions affected are particularly energy/fatigue, role limitation, physical pain and health perceptions.
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Liver disease
Liver disease and problems are very common and associated with alcohol, hepatitis, gallstones and tumors. Despite this, relatively few questionnaires have been developed. [96] [97] [98] Liver conditions affect the individual very differently depending upon the underlying condition. While cholestatic liver disease is characterized by itching and pruritus, hepatocellular disease is characterized by general tiredness and fatigue. At the end stage aschites, encephalopathy, fatigue, muscle cramps, etc. often develop and give a similar picture regardless of the basic condition. 96 The recently developed CLDQ covers both cholestatic and hepatocellular disease. 98 Hepatitis C has been studied using the SF-36 in several trials and the HRQL of the patients was found to be lower than in normal controls and hepatitis B patients, indicating a difference between the two hepatitis conditions. 99 Effect of treatment has also been studied, where SF-36 has reflected response to interferon to various degrees. 100, 101 The effect of liver transplantation is generally dramatic and will be discussed below under surgery.
Gastrointestinal cancer
Gastrointestinal cancer is very common and some types are often relatively advanced on detection. Cancer has long been a term with a high level of psychological impact due to the often negative outcome with death and severe suffering, which is well known to individuals in our society. Due to earlier and better detection and treatment, cancer has been transformed from an acute life-threatening disease to a chronic life-threatening disease. In this situation it is more important than ever to assess quality of life and understand the patients' value systems, their views on treatment and sideeffects. 102, 103 In the gastrointestinal area, evaluations have been made in patients with esophageal, 104 gastric, 105 colorectal and colorectal liver metastasis, 106, 107 and pancreatic cancers. 108 Generally, HRQL values in untreated patients after diagnosis are low, especially in connection with severe symptoms such as dysphagia and pain. Treatment that relieves symptoms or surgery, even if not curative, changes HRQL positively. This is discussed under surgery.
Effects of surgery
A number of studies have been done to assess the quality of life after surgery. In most of them, preoperative values have been low and postoperative values have been high or normal. Control groups have often been lacking, and comparisons have been made with the same group before surgery and with norm groups in the general population. In reflux disease, numerous studies have been done, most of which show improved postoperative values in most domains. [109] [110] [111] Comparisons between open and laparoscopic surgery have also been made in cholecystectomies, splenectomy and inguinal hernia. 112 Studies of the early postoperative period have not revealed major differences, which may be due to the fact that patients all come from a situation (e.g. hernia or gallstones) before surgery with very little pain. Postsurgery the pain is usually prominent, and it is hard for the individual to differentiate between open and laparoscopic surgery (as they only experience one). Ward staff have, however, reported a clear difference in patients' behavior and movement, reflecting that the evaluation instruments, in this case initially after surgery, may not be good enough (B. Hallerbäck, pers. comm., 1996). In a recent study in patients with cholecystectomy, fundoplication, incisional hernia and large bowel resections, surgery was found to improve quality of life and the conclusion was that the follow up should be a minimum of 12 months. 113 Comparisons of different types of laparoscopic reflux surgery 114 have been conducted. One study compared the impact of laparoscopic and open fundoplications in a prospective fashion. In each case adequate control of symptoms was achieved. Twelve months after the operation HRQL measures showed no difference in terms of well-being between the two interventions. However, more dyspeptic symptoms and more indigestion was observed in patients having had a laporoscopic total fundic wrap. 115 Different surgical interventions for the treatment of gastric cancer have been compared. Subtotal gastrectomy was found to be favorable to total gastrectomy when comparisons were made before and after surgery up to 1-5 years postoperatively. 116, 117 Outcomes after surgery for IBD have also been studied. Tiainen and Matikainen found patients operated with a well-functioning J-pouch were equivalent to a normal population. Bowel movements and continence after application of the J-pouch were closely related to HRQL, in that patients with more than 10 stools/day or incontinence had a low HRQL (Fig. 4) . 118 The outcome of surgery for colorectal cancer has been studied in several settings and different types of surgery and chemotherapy or specific treatment for liver metastases have been compared. However, direct comparisons of different surgical methodologies did not show any difference, which may be due to insensitivity of the questionnaires or a lack of any real differences in the outcome of the various surgical methodologies. 119 The other studies on chemotherapy and other treatment modalities suggest that quality of life can be used for surrogate end-points for choice of treatments based on patient preference and cost of treatment and effect. 106, 107 Other areas have also been studied, but we have not found it possible to cover every aspect of surgical treatment in this review.
Comparisons of surgical and medical interventions have also been performed. One such study compares antireflux surgery versus medical treatment with regard to the ability of controlling GERD symptoms in patients enrolled in a prospective randomized study. 120 The patients were followed between 10 and 13 years and a variety of measures including HRQL, satisfaction with treatment and symptom control were used. Both treatment groups show the same outcome with regard to degree of esophagitis severity and frequency of treatment for stricture or for additional antireflux surgery. Both groups also indicated the same physical and mental HRQL scores measured by the SF-36 as well as substantially the same level of satisfaction with treatment. The authors conclude that those who are satisfied with for instance, proton pump inhibitors (PPI) treatment should be advised to continue the treatment.
Other studies comparing surgical and medical interventions similarly show that during long-term follow up there is basically no discrepancy with regard to symptom control and HRQL results.
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DISCUSSION
Interactions between patients and health-care professionals are becoming increasingly complicated. Technically, development allows a more rigorous assessment of possible disease signs with serological tests and imaging. On the other hand, time pressure seldom allows comprehensive capture of psychological, social and other aspects of disease, which is increasingly important with the rapidly changing environment. To enable a positive future development, the patient's view and priorities must be better understood. This includes the needs of the individual, the relationship between HRQL and work productivity and outcomes of treatment. We also have to understand the impact of different common conditions on society. The purpose of HRQL evaluations is to go beyond the presence and severity of symptoms of disease by examining how patients perceive and experience the impact on wellbeing and daily life. Both clinicians and patients will use this information to make well-informed decision about treatment. Therefore, the patients must be in focus and important decisions regarding health care should incorporate the patient's own assessment of HRQL.
Overall, HRQL evaluations reflect the burden of illness from the patient's point of view. According to Maslow, the patient has basic needs, such as physiological requirements, security, social relationships, selfconfidence and self-actualization. If these are fulfilled, well-being is promoted. If these needs are not satisfied, anxiety, tension and stress are created. [122] [123] [124] This means that all patients will have to be treated individually to meet their needs, which may include specific treatment, explanations and understanding. For the patient, his/her symptoms are generally the major concern, regardless of whether or not the condition is medically serious. The quality of life results provide a basis for a holistic view of the patient and supplement the traditional outcomes.They may also document the full range of treatment benefits and possible side-effects and can predict the treatment outcome.
Because gastrointestinal disorders are so prevalent there has been an increasing need to assess the burden of these conditions using symptom and HRQL assessments, especially in the clinical setting. Even though alleviation of symptoms is generally well understood it is not always evident that the evaluation of treatment effects requires a more comprehensive perspective. The patient's view will always be subjective and the patients' needs should be in the focus in clinical practice. Hence, patient reported symptoms and HRQL outcomes represent important end-points in clinical trials of medical treatments in gastrointestinal diseases. More comprehensive outcome assessments are required to determine the effectiveness of new treatments for functional gastrointestinal disorders. These should be based on a combination of clinician and patient reported assessments.
With the rapid changes in society and the external environment, factors that have not been considered earlier have to be brought into the calculation as well. This will eventually broaden our understanding of disease patterns and may even add new dimensions of diseases not hitherto recognized.
Presently, HRQL evaluations meet many of the rigorous methodological needs, but new development will be necessary with time. Outcomes research is an evolving science and the full utility of these new outcome measures remains to be explored. For instance, to derive a better understanding of how symptoms affect work productivity and, similarly, to determine to what extent effective symptom control results in improved productivity. Such attempts have already been made and symptoms of reflux disease have been shown to impact on work productivity (Figs 4,5) . 125, 126 We will also have to learn more about how different demographic, clinical and other external factors such as gender, age, social situation and initial scores of anxiety and concerns influence the patient reported outcomes. This will also help us to understand diseases and correlations that make treatments good or bad or less good in individual patients. The individual preferences for outcomes and taking an individual's specific situation into consideration have to be incorporated in this. The rise in consumer concern about the possibility of realizing the full value of different medical treatments has contributed to an increasing use of patient reported outcomes when evaluating new therapies. By relying more on how the patients themselves perceive the response to new treatments clinicians are able make better clinical decisions and ultimately optimize patient management.
In the future, quality of life evaluations are most likely to be also used for assessing possible outcomes of various medical treatments and surgical interventions. The prognosis of diseases also falls within the scope of these evaluations and has been investigated in conjunction with medical therapies in patients with reflux disease, with and without esophagitis (Wiklund et al., unpubl. data, 2001 ). Similarly, the prognostic power of patient reported outcomes has already been suggested in open heart surgery and cancer treatment 127 and to document the effect of transplantation and coronary bypass surgery, where transplantation was found to be significantly better. 128 As with all clinical end-points the results obtained in trials and evaluations may become flawed by different factors. For instance, if only the values of patients remaining in a clinical trial are analyzed omitting the values of patients who leave the study prematurely due to side-effects or because they perceive that the treatment does not work, the end results might not show any difference.Therefore, care must be taken to monitor the results of all patients who discontinue a study. One example can be found in the evaluation of surgical interventions. If only the survivors are evaluated the results tend to be good (E. Eypash, pers. comm., 2000).
The use and understanding of HRQL has not yet been fully explored. Today, HRQL evaluations can help us to understand how a disease and symptoms impact on a patient group and individuals. By carefully applying HRQL information received in clinical trials we can predict outcome of treatment in different patient groups. Health-related quality of life assessments may also facilitate an understanding of the relationship between different diseases. To be able to use HRQL in individual patients in a broader sense understanding has to be increased and the instruments need to be further developed. Already today, assessments can be made in an individual consultation and this may help communication. The potential for the future is, however, considerable when the right questionnaire is connected to the right technical development with, for example, hand-held computers drawing out a profile of the individual, taking away time constraints and problems with assessing the evaluations.This will potentially add another dimension to the patient health-care interaction, tailor-making treatment and care for the individual.
